Expert consensus on clinical application management of fecal microbiota transplantation (2022 edition).
10.3760/cma.j.cn441530-20220725-00324
- VernacularTitle:肠道菌群移植临床应用管理中国专家共识（2022版）
- Collective Name:National Institute of Hospital Administration, NHC;Society of Parenteral and Enteral Nutrition, Chinese Medical Association;Intestinal Microecology Cooperative Group, Chinese Society for Parenteral and Enteral Nutrition
- Publication Type:Journal Article
- MeSH:
Consensus;
Fecal Microbiota Transplantation;
Feces/microbiology*;
Gastrointestinal Microbiome;
Humans;
Intestinal Diseases
- From:
Chinese Journal of Gastrointestinal Surgery
2022;25(9):747-756
- CountryChina
- Language:Chinese
-
Abstract:
Fecal microbiota transplantation (FMT) is to transplant the functional intestinal bacteria from human feces into the intestinal tract of patients, reconstruct the new intestinal flora and treat intestinal and extra-intestinal diseases. During the past 10 years, FMT has made a breakthrough in the treatment of intestinal and extra-intestinal diseases, and provided a brand-new strategy to the treatment of intestinal and extra-intestinal diseases. In view of the fact that FMT lacks a unified clinical management standard at home and abroad, relevant regulations and policies still need to be improved, and clinical application experience still needs to be accumulated, the National Institute of Hospital Administration, National Health Commission commissioned a clinical FMT expert working group to organize experts in related fields. Based on thorough analysis of relevant literature, policies and norms internationally, as well as the mature experience of FMT in many medical institutions in China, an expert consensus for clinical management of FMT in medical institutions is compiled to further strengthen its clinical application and standard management, so as to improve the safety and efficacy of FMT.
